Early bone mineral density loss after renal transplantation and pre-transplant PTH: A prospective study

Kidney and Blood Pressure Research

Volumn 31, Issue 3, 2008, Pages 196-202

  Bubenicek, Petr ^a   Sotornik, Ivo ^a   Vitko, Stefan ^a   Teplan, Vladimir ^a  

^a INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

Author keywords

Bisphosphonates; Bone mineral density; Hyperparathyroidism; Immunosuppression; Post transplant osteopathy; Renal failure

Indexed keywords

PARATHYROID HORMONE;

ADULT; AGED; ARTICLE; BONE DENSITY; BONE DISEASE; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HORMONE BLOOD LEVEL; HUMAN; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OSTEOLYSIS; PRIORITY JOURNAL;

ADULT; AGED; BONE DENSITY; BONE DISEASES, METABOLIC; COHORT STUDIES; FEMALE; HUMANS; KIDNEY TRANSPLANTATION; LUMBAR VERTEBRAE; MALE; MIDDLE AGED; PARATHYROID HORMONE; PROSPECTIVE STUDIES; TIME FACTORS;

EID: 46249115645     PISSN: 14204096     EISSN: None     Source Type: Journal    
DOI: 10.1159/000137287     Document Type: Article

References (30)

1. Malluche HH, Faugere MC: Renal bone disease 1990: an unmet challenge for the nephrologist. Kidney Int 1990;38:193-211.
2. Sherrard DJ, Hercz G, Pei Y, et al: The spectrum of bone disease in end-stage renal failure: an evolving disorder. Kidney Int 1993; 43:436-442.
3. Monier-Faugere M-C, Mawad H, Qi Q, et al: High prevalence of low bone turnover and occurrence of osteomalacia after kidney transplantation. J Am Soc Nephrol 2000;11: 1093-1099.
4. Babarykin D, Adamsone T, Amerika D, et al: Disorders of calcium metabolism at various times after renal transplantation. Ann Transplant 1999;4:46-53.
5. Leidig-Bruckner G, Hosch S, Dodidou P, et al: Frequency and predictors of osteoporotic fractures after cardiac or liver transplantation. Lancet 2001;357:342-347.
6. Cayco AV, Wysolmerski J, Simpson CH, et al: Post-transplant bone disease: evidence for a high bone resorption intake. Transplantation 2000;70:1722-1728.
7. Heaf J, Tvedegaard E, Kanstrup IL, Fogh-Andersen N: Bone loss after renal transplantation: role of hyperparathyroidism, acidosis, cyclosporine and systemic disease. Clin Transplant 2000;14:475-463.
8. Aroldi A, Tarantino A, Montagnino G, et al: Effect of three immunosuppressive regimes on vertebral bone density in renal transplant recipients. Transplantation 1997;63:380-386.
9. Julian B, Laskow D, Dubovsky J, et al: Rapid loss of vertebral mineral density after renal transplantation. N Engl J Med 1991;325:544-549.
10. Martins L, Queiros J, Ferreira A, et al: Renal osteodystrophy: histologic evaluation after renal transplantation. Transplant Proc 2000; 32:2599-2601.
11. Weber TJ, Quarles LD: Preventing bone loss after renal transplantation with bisphosphonates: we can... but should we? Kidney Int 2000;57:735-737.
12. Bianda T, Linka A, Junga G, et al: Prevention of osteoporosis in heart transplant recipients: a comparison of calcitriol with calcitonin and pamidronate. Calcif Tissue Int 2000; 67:116-121.
13. Pichette V, Bonnardeaux A, Prudhomme L, et al: Long-term bone loss in kidney transplant recipients: a cross-sectional and longitudinal study. Am J Kidney Dis 1996;28:105-114.
14. Grotz WH, Rump LC, Niessen A, et al: Treatment of osteopenia and osteoporosis after kidney transplantation. Transplantation 1998;66:1004-1008.
15. Giannini S, D'Angelo A, Carraro G, et al: Persistently increased bone turnover and low bone density in long-term survivors to kidney transplantation. Clin Nephrol 2001;56: 353-363.
16. Almond MK, Kwan JTC, Evans K, Cunningham J: Loss of regional bone mineral density in the first 12 months following renal transplantation. Nephron 1994;66:52-56.
17. Carlini RG, Rojas E, Weisinger JR, et al: bone disease in patients with long-term renal transplantation and normal renal function. Am J Kidney Dis 2000;36:160-166.
18. Torres A, García S, Gomez A, et al: Treatment with intermittent calcitriol and calcium reduces bone loss after renal transplantation. Kidney Int 2004;65:705-712.
19. Valero MA, Loinaz C, Larrodera L, et al: Calcitonin and bisphosphonates treatment in bone loss after liver transplantation. Calcif Tissue Int 1995;57:15-19.
20. Shane E, Rodino MA, McMahon DJ, et al: Prevention of bone loss after heart transplantation with antiresorptive therapy: a pilot study. J Heart Lung Transplant 1998;17: 1089-1096.
21. Fan SL, Almond MK, Ball E, et al: Pamidronate therapy as prevention of bone loss following renal transplantation. Kidney Int 2000;57:684-690.
22. Grotz AU, Nagel C, Poeschel D, et al: Effect of ibandronate on bone loss and renal function after kidney transplantation. J Am Soc Nephrol 2001;12:1530-1537.
23. Coco MK, Glichlich D, Faaugere MC, Burris L, Bognar I, Durkin P, Tellis V, Greenstein S, Schechner R, Figuueroa K, McDonough P, Wang G, Malluche H: Prevention of bone loss in renal transplant recipients: a prospective randomized trial of intravenous pamidronate. J Am Soc Nephrol 2003;14:2669-2676.
24. Piraino B, Chen T, Cooperstein L, et al: Fractures and vertebral bone mineral density in patients with renal osteodystrophy. Clin Nephrol 1988;30:57-62.
25. Zehnder D, Bland R, Walker EA, et al: Expression of 25-hydroxyvitamin D3-1α hydroxylase in the human kidney. J Am Soc Nephrol 1999;10:2465-2473.
26. Dissanayker IR, Epstein S: The fate of bone after renal transplantation. Cur Opin Nephrol Hyperten 1998;7:389-395.
27. Torres A, Lorenzo V, Sallido E: Calcium metabolism and skeletal problems after transplantation. J Am Soc Nephrol 2002;13:551-558.
28. Ogawa T, Tokuda M, Tomizawa K, et al: Osteoblastic differentiation is enhanced by rapamycin in rat osteoblast-like osteosarcoma (ROS 17/2.8) cells. Biochem Biophys Res Commun 1998;249:226-230.
29. Block GA, Martin KJ, de Francisco ALM, et al: Cinacalcet hydrochloride for secondary hyperparathyroidism in patients receiving hemodialysis. N Engl J Med 2004;350:1520-1529.
30. National Kidney Foundation: K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003;42(suppl 3):1-201.